Page last updated: 2024-09-05

sb 203580 and Pemphigoid

sb 203580 has been researched along with Pemphigoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beckmann, T; Boehncke, WH; Hänsel, M; Hellberg, L; Holdorf, K; Kirchner, T; Laskay, T; Ludwig, RJ; Möckel, N; Recke, A; Samavedam, UKSRL; Schmidt, E; Solbach, W; Steinhorst, K; Zillikens, D1

Other Studies

1 other study(ies) available for sb 203580 and Pemphigoid

ArticleYear
Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation.
    The Journal of investigative dermatology, 2013, Volume: 133, Issue:10

    Topics: Adult; Animals; Antigen-Antibody Complex; Autoantibodies; Butadienes; Dermis; Disease Models, Animal; Enzyme Inhibitors; Epidermal Cells; Epidermis; Epidermolysis Bullosa Acquisita; Glucocorticoids; Humans; Imidazoles; MAP Kinase Signaling System; Methylprednisolone; Mice; Mice, Inbred C57BL; Neutrophils; Nitriles; Pemphigoid, Bullous; Pyridines; Reactive Oxygen Species; Respiratory Burst

2013